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Abstract Leukocytes kill microbes by producing reactive oxy-
gen species, using a multi-component enzyme complex, nicotin-
amide adenine dinucleotide phosphate (NADPH) oxidase. Elec-
trons pass from intracellular NADPH through a redox chain
within the enzyme, to reduce extracellular O2 to O32 . Electron
£ux is electrogenic, and rapidly depolarizes the membrane po-
tential. Excessive depolarization can turn o¡ electron transport
by self-inhibition, but this is prevented by proton £ux that bal-
ances the electron £ux. Although the membrane potential depo-
larizes by V100 mV during the respiratory burst (NADPH
oxidase activity), NADPH oxidase activity is independent of
voltage in this range, which permits optimal function and pre-
vents self-inhibition.
, 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Key words: Phagocyte; Respiratory burst; Ion channel;
Membrane potential ; Superoxide; pH
1. Introduction
Pathways for electron and proton transport occur in many
molecules involved in the conversion of light or food into
stored energy. The ‘central dogma of membrane bioenergetics’
[1] states that electron translocation creates a proton gradient
(protonmotive force) across the mitochondrial inner mem-
brane (or chloroplast thylakoid membrane, or bacterial plas-
ma membrane) that is used to generate ATP [2,3]. Many of
the membrane proteins involved in these bioenergetic func-
tions incorporate pathways for both protons and electrons.
This review describes proton and electron translocation in
the system used by phagocytes (a subset of circulating white
blood cells) to generate superoxide anion, O32 , which contrib-
utes to pathogen killing and also participates in intra- or
intercellular signaling. This process is called the ‘respiratory
burst’ because oxygen consumption increases dramatically [4].
In the phagocyte system (Fig. 1), distinct molecules mediate
electron and proton transport. The nicotinamide adenine di-
nucleotide phosphate (NADPH) oxidase enzyme complex
moves electrons across the membrane from intracellular
NADPH to extracellular O2 to generate O32 . Proton e¥ux is
mediated by a distinct and separate pathway, the composition
of which has yet to be identi¢ed [5,6].
2. NADPH oxidase is electrogenic and voltage-sensitive
Since NADPH oxidase was ¢rst proposed to be electrogenic
by Lydia Henderson, Brian Chappell, and Owen Jones [7], it
was assumed that the electron £ux would have to be balanced
to maintain electroneutrality. Henderson and colleagues ob-
served electrogenic Hþ e¥ux during the respiratory burst,
which they proposed to be the compensatory mechanism.
Five years earlier, also at Bristol, Roger Thomas and Bob
Meech had described the existence of voltage-gated proton
channels in snail neurons [8]. Henderson et al. [7] suggested
that a similar channel might exist in phagocytes and mediate
charge compensation. Subsequently, voltage-gated proton
channels were demonstrated directly by patch-voltage-clamp
in human neutrophils [9] and other mammalian cells [10^12].
Recent studies have examined (a) the extent to which charge
compensation is actually required, (b) whether it is mediated
by Hþ e¥ux or Kþ e¥ux [13], and (c) whether Hþ e¥ux is
mediated by voltage-gated proton channels or another path-
way.
If NADPH oxidase is electrogenic, then at least one step in
the electron transport process must be voltage-dependent [14].
Furthermore, the presumed requirement for charge compen-
sation implies, by its obverse, that su⁄cient depolarization
would prevent electrons from leaving the cell and thus inhibit
enzyme function. Until recently, the voltage dependence of
electron transport had been measured only over a narrow
voltage range. Because electrons are transported across the
entire membrane (unlike most components in electron trans-
port chains of energy conversion), the activity of the enzyme
can be measured directly as an electron current [15,16]. Acti-
vation of phagocytes by phorbol esters (PMA, phorbol myr-
istate acetate) results in assembly and function of the NADPH
oxidase complex [16], which can be studied using the permea-
bilized-patch variant [17] of the patch-clamp technique [18].
Fig. 2 illustrates the measurement of electron current (Ie) over
a wide voltage (V) range [19]. These data con¢rm that
NADPH oxidase activity is strongly voltage-dependent, and
show that depolarization to +200 mV abolishes NADPH ox-
idase function. Surprisingly, the Ie^V relationship is highly
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non-linear (Fig. 2b,c). NADPH oxidase activity is steeply vol-
tage-dependent at large positive voltages, but nearly indepen-
dent of membrane potential at negative voltages. In intact
neutrophils the membrane potential depolarizes from a resting
potential of roughly 360 to 380 mV [20], to +58 mV during
the respiratory burst [21]. Teleologically, then, the voltage-in-
dependent region is bene¢cial because it means that the oxi-
dase does not inhibit itself throughout the physiological range
of membrane potentials. The strong recti¢cation of the Ie^V
relationship suggests that two distinct steps in electron trans-
Fig. 1. Cartoon illustrating the NADPH oxidase complex in phagocytes and the related voltage-gated proton channel. In a resting phagocyte
(neutrophil, macrophage, or eosinophil), gp91phox and p22phox are present in the membrane as a heterodimer, and the other four components
are located in the cytosol. Upon stimulation by various agents, all the components assemble to form a functional complex. From [20].
Fig. 2. Voltage dependence of electron current generated by NADPH oxidase during its function in a living human eosinophil. a: The voltage
was ramped from 3100 mV to +200 mV or more, after activation of NADPH oxidase by 60 nM PMA. Electron current generated by
NADPH oxidase (Ie) was isolated by inhibiting NADPH oxidase function with diphenyleneiodonium (DPI). b: The residual current in the pres-
ence of DPI (open symbols) was subtracted from the total current (solid symbols) to give the net Ie. c: Examples of the Ie^voltage relationship
in four cells. Experiments were done in the presence of 5 mM ZnCl2 to inhibit Hþ currents, which would have been hundreds of picoamperes
in amplitude in these cells. From [19].
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port are rate-determining at di¡erent voltages [19]. We thus
need to consider the electron pathway.
3. The electron pathway
Although the NADPH oxidase complex has many compo-
nents, the probable electron pathway, illustrated in Fig. 3, is
contained within a single subunit. The gp91phox component of
NADPH oxidase appears to contain both hemes (denoted
cytochrome b in Fig. 3) as well as the binding sites for
NADPH, £avin adenine dinucleotide (FAD), and presumably,
O2 [22]. The other components of the enzyme complex play
various roles in assembly and regulation of function [23]. Five
components (gp91phox, p67phox, p47phox, p22phox, and Rac) are
su⁄ciently indispensable that their absence, due to mutation,
results in chronic granulomatous disease (CGD) [4]. Without
medical intervention, the severe impairment of microbial kill-
ing in CGD leads to signi¢cant morbidity and mortality sec-
ondary to recurrent infection. During the ‘respiratory burst’,
the rapid increase in O2 consumption that occurs during
phagocytosis [24], two electrons are removed from NADPH
in separate steps, and are translocated along the pathways
diagrammed in Fig. 3. The chemical midpoint potentials in
Fig. 3 indicate that the pathways generally favor electron
translocation from intracellular NADPH to extracellular O2.
4. What is the rate-limiting step?
Looking in more detail, we see that the two hemes in £a-
vocytochrome b558 are bis-histidine-ligated and that the rele-
vant His residues are 13 or 14 amino acid residues apart in
cytochrome b558 of NADPH oxidase [22]. A very similar ar-
rangement is seen in cytochrome bc1 and in a synthetic multi-
heme protein in which the heme-ligating His are both 14 res-
idues apart [25,26], which corresponds to a 20^21 AT separa-
tion between the redox centers [26,27]. Long-range electron
transfer in proteins is well documented [28,29]. Although the
intervening medium plays a profound role in electron transfer
between redox metals [30], the dominant factor that regulates
the rate of electron transfer within proteins is the distance
between the participating redox donor and acceptor [31^33].
Electron transfer between redox centers within a protein sep-
arated by 20^21 AT (center-to-center) typically occurs at 103^
106 s31 [30]. Considering the mildly unfavorable energetics of
heme1Cheme2 transfer in NADPH oxidase, the actual turn-
over rate ofV300^330 s31 [34,35] falls quite reasonably at the
lower end of the range of observed electron transfer rates.
Taken together, the location of both His within the membrane
based on hydropathy analysis [22], the relatively slow pre-
dicted rate of electron transfer over such a long distance,
and the ‘uphill’ energetics of the heme1Cheme2 transfer
(Fig. 3) strongly implicate this step as being the voltage-sen-
sitive process that is rate-determining at large positive voltages
(Fig. 2).
Even more interesting is the voltage-independent region,
because this includes the entire physiological range of mem-
brane potentials. We expect that due to the large electrical
driving force, heme1Cheme2 electron transfer is rapid at neg-
ative voltages, and another step that is insensitive to mem-
brane potential is rate-determining. At present, we can only
speculate as to the identity of this step. The ¢nal reduction of
O2 to O32 seems an unlikely candidate, because O
3
2 produc-
tion is not limited by substrate O2 concentration down to
V5% of atmospheric O2 levels [36]. However, this evidence
indicates only that the association of O2 with the oxidase is
not rate-determining. Future studies are needed to resolve this
question.
5. Electron transport through NADPH oxidase in phagocytes
requires proton e¥ux
The fact that depolarization alone can shut o¡ NADPH
oxidase activity (Fig. 2) graphically demonstrates that charge
compensation is absolutely necessary for sustained oxidase
function. Strong evidence implicates Hþ e¥ux through vol-
tage-gated proton channels as the primary mechanism of
charge compensation. Activation of NADPH oxidase results
in profound depolarization if H currents, and consequent
charge compensation, are inhibited by the divalent cations
Cd2þ and especially Zn2þ (preventing charge compensation)
[7,37^39]. Furthermore, Hþ current inhibitors block O32 pro-
duction [19,40^44]. However, the evidence is not quite as
straightforward as one might like, because in every study,
the concentrations of metals that inhibit O32 production
greatly exceed those required to inhibit Hþ channels. The res-
olution of this apparent contradiction is discussed below.
In Fig. 4a, the inhibition of O32 production by Zn
2þ is
illustrated for neutrophils and eosinophils. Although the latter
Fig. 3. Diagram showing the presumed electron pathways through
the NADPH oxidase complex. The ¢rst electron removed from
NADPH passes through the lower pathway, the second through the
upper. Depicting two pathways is schematic; both electrons pass
through the same two hemes, but at di¡erent times, and with
slightly di¡erent energetics. The chemical midpoint potentials are
given. This ¢gure was generously provided by Andrew R. Cross.
Fig. 4. a: The maximum rate of O32 release, assessed as cytochrome
c reduction, is plotted in cells stimulated by PMA in the presence of
various concentrations of ZnCl2. Mean and S.E.M. are plotted for
four batches of human eosinophils (R), nine of human neutrophils
(b), and four of COSphox cells (E). b: The human phagocyte data
from panel a are replotted after normalization, along with measure-
ments in the presence of PMA, ZnCl2, and the protonophore
CCCP, which partially restored function. From [19].
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assemble more NADPH oxidase complexes in the plasma
membrane [45] and generate O32 about three times faster
than do stimulated neutrophils, the normalized concentra-
tion^response curves superimpose (Fig. 4b). Similar measure-
ments in the non-phagocytic cell line COS-7, stably trans-
fected with the essential NADPH oxidase components
(which we term COSphox cells, in Fig. 4a) [46] reveal insensi-
tivity to Zn2þ. COS-7 cells were selected for study because
they lack endogenous NADPH oxidase as well as voltage-
gated proton channels [6,47]. Transfection with NADPH ox-
idase components invests them with the capacity to exhibit
agonist-dependent superoxide generation (Fig. 4a), although
to a lesser degree than that seen in phagocytes. However, in
contrast to phagocytes, the superoxide generation in the het-
erologously transfected COSphox cells is insensitive to Zn2þ.
Insensitivity of oxidase activity in COSphox cells to Zn2þ sup-
ports the idea that the e¡ects of Zn2þ in phagocytes are due to
inhibition of Hþ channels. The mechanism of charge compen-
sation in COSphox cells is not known. Nevertheless, the lack of
inhibition of O32 production by Zn
2þ in COSphox cells indi-
cates that Zn2þ acts on Hþ channels rather than, for example,
some step in the assembly of the NADPH oxidase complex.
Additional evidence that Hþ e¥ux is required for NADPH
oxidase activity is shown in Fig. 4b. In the presence of ZnCl2,
O32 production is partially restored by addition of the proto-
nophore CCCP [19]. In contrast, the Kþ ionophore valinomy-
cin does not restore O32 production in the presence of metal
inhibitors [41].
It was mentioned above that the metal concentrations that
inhibit O32 production (e.g. 0.1^0.3 mM, Fig. 4a) are orders of
magnitude greater than those required to inhibit Hþ channels.
Voltage-gated proton currents in phagocytes are clearly re-
duced by as little as 1 WM Zn2þ [38,48]. An appreciation of
the mechanism by which Zn2þ inhibits Hþ currents is key to
resolving this apparent discrepancy. Zn2þ does not ‘block’ the
Hþ channel, in the classical sense of a cork plugging a bottle,
but rather binds to a site on the external side of the channel
where it slows opening and shifts the voltage dependence of
gating to more positive voltages [49]. This shift in voltage
sensitivity occurs by a mechanism ¢rst proposed by Andrew
Huxley in discussions with Bernard Frankenhaeuser and Alan
Hodgkin [50]. When a divalent cation binds at the external
side of the membrane, a protein within the membrane will
sense an altered local electrical ¢eld. Due to the greater pos-
itive charge at the extracellular side of the membrane (by the
usual convention membrane potential is the voltage inside
minus the voltage outside), the channel will behave as if the
membrane potential is more negative than it actually is. Ac-
cordingly, a greater applied depolarization will be necessary to
cause a depolarization-activated channel to open.
6. What does this mean to a phagocyte?
When the respiratory burst is activated in a phagocyte, the
Hþ channel properties are modulated to enhance the proba-
bility that the channel is open. The voltage at which Hþ
channels start to open, Vthreshold, shifts about 340 mV, from
roughly +20 mV in a resting cell to 320 mV after stimulation
of NADPH oxidase [16]. The electrogenic action of NADPH
oxidase will rapidly depolarize the membrane beyond Vthreshold
and depolarization will continue until enough Hþ channels
open and until the driving force (V3EH, the di¡erence be-
tween the membrane potential, V, and the Nernst potential
for Hþ, EH) increases to the point at which proton e¥ux
exactly balances electron e¥ux. Empirically, this occurs at
+58 mV in human neutrophils [21] and +17 mV in human
eosinophils [39]. We know that Zn2þ concentrations s 0.1^0.3
mM are necessary to inhibit O32 production (Fig. 4a). The
shift of Vthreshold that this concentration of Zn2þ will cause
can be estimated to be 80^90 mV, based on the empirical
relationship determined by Cherny and DeCoursey [49] :
ln(13PZn)31U10 mV, where PZn is the probability that the
Zn2þ receptor on the Hþ channel is occupied by Zn2þ. Thus,
Vthreshold will shift to +60 or +70 mV, into the region of the
current^voltage relationship where NADPH oxidase activity
is steeply voltage-dependent. The electron current amplitude
will be reduced rapidly by any additional depolarization,
hence O32 production will be reduced proportionately. Thus,
the observed e¡ect of Zn2þ on phagocyte NADPH oxidase
activity re£ects a metal-dependent shift in the sensitivity of the
proton channel to membrane potential. What appeared for
years to be a chink in the argument supporting a role for
Hþ channels in the respiratory burst turns out to be com-
pletely predictable from the strong recti¢cation of the Ie^V
relationship.
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